ÌÇÐÄÊÓÆµ Therapeutics Announces the First Patient Dosed with MST-0312 in the Phase I STARLYS Trial
May 19, 2026
Read More

ÌÇÐÄÊÓÆµ in the News
BioCentury Article:ÌýÌÇÐÄÊÓÆµ: Attacking Tumors from Within
Fierce Biotech: